Tenders

NHS National Generic Pharmaceuticals Transition 2021_1

Closed

Submission Deadline Has Passed

This tender's submission deadline has passed and is no longer accepting applications. The information below is kept for reference purposes.

Browse Active Tenders
Deadline
Expired
March 17, 2021
Contract Details
Category
Other
Reference
009271-2021
Value
£39
Location
United Kingdom
Published
February 23, 2026
CPV Code
Project Timeline

Tender Published

April 29, 2021

Deadline for Questions

March 10, 2021

Submission Deadline

March 17, 2021

View Original
Budget
£39
Duration
Not specified
Location
United Kingdom
Type
Other

Original Tender Description

Transition and 33 % products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months).The total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months).

Risk Analysis

Please log in to use risk analysis.

Login

Win Strategy

Please log in to access winning strategy recommendations.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI requirements analysis not yet available for this tender.

Requirements will be generated automatically when tender documents are processed.

Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

No processed documents available for this tender.

Documents will appear here once they are downloaded and analyzed.

Analysis Pending

Quality analysis for this tender is being processed. Please check back shortly.

Add to Pipeline